Results 101 to 110 of about 16,702 (172)

Pi-pi stacking interactions with viral DNA contribute to the potency of naphthyridine-based HIV-1 integrase inhibitors. [PDF]

NAR Mol Med
Zhao XZ, Li M, Smith SJ, Karbasi A, Choudhuri I, Jing T, Lyumkis D, Craigie R, Burke TR.   +8 more
europepmc   +1 more source

Drug Resistance to HIV-1 Integrase Inhibitors Among Treatment-Naive Patients in Beijing, China. [PDF]

Pharmgenomics Pers Med, 2022
Yu F, Li Q, Wang L, Zhao H, Wu H, Yang S, Tang Y, Xiao J, Zhang F.   +8 more
europepmc   +1 more source

Diagnostic Accuracy of Next-Generation Sequencing: Prevalence of HIV-1 Drug Resistance and Associated Factors Among Adults on Integrase Inhibitors with Virologic Failure. [PDF]

Viruses
Lunkuse S, Kiiza R, Ssekagiri A, Nannyonjo M, Ntenkaire N, Nassolo F, Namagembe HS, Kiberu F, Kabuuka D, Andia I, Kalyango JN, Kibwika PB, Bbosa N, Kaleebu P, Ssemwanga D.   +14 more
europepmc   +1 more source

Exploring the Potential of HIV Integrase Inhibitors as Therapeutic Agents Against HSV and HCMV: A Molecular Docking Study. [PDF]

J Exp Pharmacol
Rao AM, Sm F, Somashekara D, Gayam PKR, Rahangdale RR, Patil SS, Hariharapura RC.   +6 more
europepmc   +1 more source

First report of computational protein-ligand docking to evaluate susceptibility to HIV integrase inhibitors in HIV-infected Iranian patients. [PDF]

Biochem Biophys Rep, 2022
Ghasabi F, Hashempour A, Khodadad N, Bemani S, Keshani P, Shekiba MJ, Hasanshahi Z.   +6 more
europepmc   +1 more source

BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV-Infected Patients. [PDF]

AIDS Res Treat
Pérez-Calvo F, Jover-Diaz F, Delgado-Sánchez E, Peris-García J, Bernabéu-Martínez MÁ.   +4 more
europepmc   +1 more source

Socioeconomic status largely explains integrase inhibitors-related body composition differences in chronically infected men living with HIV. [PDF]

Antivir Ther, 2022
Wisch JK, Cooley SA, Yarasheski KE, Cade WT, Reeds DN, Nelson B, Alemu R, Burdo TH, Ances BM.   +8 more
europepmc   +1 more source

Risk of Immune Reconstitution Inflammatory Syndrome With Integrase Inhibitors Versus Other Classes of Antiretrovirals: A Systematic Review and Meta-analysis of Randomized Trials. [PDF]

J Acquir Immune Defic Syndr, 2022
Zhao Y, Hohlfeld A, Namale P, Meintjes G, Maartens G, Engel ME.   +5 more
europepmc   +1 more source

Experience of a Nationwide implementation of single-tablet second-generation integrase inhibitors-based treatment in Mexico. [PDF]

IJID Reg
Piñeirúa-Menéndez A, Caro-Vega Y, Mosqueda-Gómez JL, Ríos SÁ, Badial-Hernández F, la Torre-Rosas A, Sierra-Madero J.   +6 more
europepmc   +1 more source

Is less truly more? - reassessing antiretroviral efficacy - a safety analysis for HIV patients switching from triple to double regimens with integrase inhibitors: A systematic review and meta-analysis. [PDF]

Medicine (Baltimore)
Jover F, Martínez-Sanz J, Antela A, López-Cavanillas M, Viguera-Moreno M, González-Rodríguez P, Domingo P.   +6 more
europepmc   +1 more source